Clinical trial
Management of Uterine Arteriovenous Malformation- a Comparison of 2 Management Possibilities- Observation vs. Progesterone Treatment/ a Randomized Control Trial
NCT05491343 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Uterine Arteriovenous Malformation- a Comparison of 2 Management Possibilities- Observation vs. Progesterone Treatment/ a Randomized Control Trial
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2022
- Completion date
- January 31, 2024
- Enrollment
- 28 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.